$CNTB Has Two Phase 2 Results Coming This Month. Anyone Else Watching This?

{"summary": "Author is watching CNTB ahead of two Phase 2 trial results for rademikibart in asthma and COPD expected in September, with $31.5M cash providing over a year of runway.", "reason": "The author provides a clear watch thesis for CNTB based on upcoming Phase 2 trial results and cash runway.", "ideas": [{"symbol": "CNTB", "direction": "watch", "thesis": "Author is watching CNTB because two Phase 2 trial results for rademikibart in asthma and COPD are expected in September, with 160 and 159 patients respectively. If results are strong, the company plans to meet with the FDA about moving toward Phase 3, which could bring significantly more attention to the stock. The company reported about $31.5 million in cash and investments, enough to fund operations for at least another year. The main risk is that everything now depends on the trial results.", "thesis_short": "CNTB Phase 2 results due September", "quote": "They have a drug called rademikibart being tested for asthma and COPD, and two Phase 2 trial results are expected in September.", "confidence": 0.75, "sentiment": 0.5, "timeframe": "September"}], "model": "gemini-3.1-flash-lite", "verified": true, "extraction_model": "deepseek-v4-flash"}